- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on ALK or ROS1-positive NSCLC
Total 35134 results
-
Oncology Institute of Southern SwitzerlandEnte Ospedaliero Cantonale, Bellinzona; Clinical Trial Unit Ente Ospedaliero... and other collaboratorsActive, not recruitingNSCLC Stage IVSwitzerland
-
AIO-Studien-gGmbHAstraZenecaWithdrawn
-
Hunan Province Tumor HospitalCompletedNon-squamous NSCLCChina
-
Amsterdam UMC, location VUmcUnknown
-
Hoffmann-La RocheRecruitingALK Fusion-positive Solid or CNS TumorsUnited States, Korea, Republic of, China, Spain, Canada, United Kingdom, Australia, Denmark, France, Italy, Germany
-
Institute of Cancer Research, United KingdomActive, not recruitingNSCLCUnited Kingdom, France, Switzerland, Italy, Spain
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
ZivenaUnknown
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Stanford UniversityTerminatedLung Cancer | Mesothelioma | Lung Cancer Non-Small Cell Cancer (NSCLC) | Lung Cancer Small Cell Lung Cancer (SCLC)United States
-
Shandong Cancer Hospital and InstituteRecruitingUnresectable Stage III NSCLCChina
-
Molecular Partners AGTerminatedEGFR-mutated NSCLC (Disorder)United States
-
Fujian Cancer HospitalEnrolling by invitationEGFR/ ALK-negative Advanced NSCLCChina
-
University of ParmaMonash Medical Centre; University Hospital of TorrejonRecruitingInstrumental Delivery | NEC, Affecting Fetus or Newborn | Second Stage Cesarean Delivery | Occiput PositionItaly
-
VelosBio Inc.CompletedGastric Cancer | Pancreatic Cancer | NSCLC | Platinum-resistant Ovarian Cancer | Triple-negative Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast Cancer | Non-squamous Non-small-cell Lung Cancer | Estrogen-receptor-positive Breast Cancer | Progesterone-receptor-positive Breast Cancer | Estrogen-receptor-negative... and other conditionsUnited States, Canada
-
Mt. Sinai Medical Center, MiamiAmgenCompletedUnresectable Locally Advanced NSCLCUnited States
-
Eli Lilly and CompanyCompletedHistological or Cytological Diagnosis of Locally Advanced or Metastatic NSCLC of Nonsquamous Histology and Not Amenable to Curative Therapy.Hungary, Germany, Austria, Spain, Sweden
-
Xiangya Hospital of Central South UniversityRecruitingResectable/Potentially Resectable NSCLCChina
-
Tang-Du HospitalRecruitingNSCLC Stage IV | OligometastasisChina
-
Intergroupe Francophone de Cancerologie ThoraciqueBristol-Myers Squibb; Pierre Fabre Laboratories; Ligue contre le cancer, FranceCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...RecruitingNSCLC Stage IV | ALK Fusion Protein ExpressionUnited States
-
ETOP IBCSG Partners FoundationAstraZenecaActive, not recruitingNSCLC Stage IV | EGFR Gene MutationSingapore, Sweden, Korea, Republic of, Spain, Switzerland, Netherlands, Italy, Poland
-
ETOP IBCSG Partners FoundationMirati Therapeutics Inc.RecruitingNSCLC Stage IV | KRAS P.G12CIreland, Italy, France, Spain, United Kingdom, Belgium
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruiting
-
University Hospital, GenevaSwiss National Science Foundation; University of Applied Sciences of Western...CompletedDystocia | Maternal Distress in Labor | Persistent Occipitoposterior or Occipitoanterior Position | Fetal Position and Presentation AbnormalitiesSwitzerland
-
Novartis PharmaceuticalsAvailableNon-small Cell Lung Cancer (NSCLC) | Anaplastic Lymphoma Kinase (ALK)- Positive Tumors
-
Jun Zhang, MD, PhDNilogen OncosystemsRecruitingNSCLC | Lung Cancer | NSCLC Stage IVUnited States
-
Harbin Medical UniversityJiangsu HengRui Medicine Co., Ltd.Unknown
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingNSCLC Stage IV | ALK Gene Mutation | ALK Sensitizing MutationItaly
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
LMU KlinikumDepartment of Internal Medicine V, Thoracic Oncology Centre Munich, LMU Munich... and other collaboratorsRecruitingOncology | NSCLC, Stage III | Chemoradiotherapy | Biomarker | DurvalumabGermany
-
AmgenActive, not recruitingKRAS p, G12c Mutated /Advanced Metastatic NSCLCFinland, United States, Canada, Belgium, Spain, Korea, Republic of, Netherlands, United Kingdom, Australia, Denmark, Hungary, Sweden, Taiwan, Greece, Russian Federation, Switzerland, France, Italy, Japan, Poland, Brazil, Germany, Po...
-
The Affiliated Hospital of Qingdao UniversityUnknownNSCLC Stage IV | PD-1 | ARID1AChina
-
Myriad Genetic Laboratories, Inc.TerminatedNSCLC | Lung Cancer | NSCLC AdenocarcinomaUnited States
-
The First Affiliated Hospital, Guangzhou University...Not yet recruiting
-
Vestre Viken Hospital TrustOdense University Hospital; Karolinska University Hospital; Oslo University Hospital and other collaboratorsRecruitingCancer | Lung Cancer | NSCLC Stage IV | Mutation | NSCLC, Stage III | Lung Cancer Stage IV | Cancer, LungNorway
-
Yonsei UniversityRecruitingPotentially Resectable Stage II/IIIa NSCLCKorea, Republic of
-
Fudan UniversityCompletedNSCLC Stage IV | EGFR Activating MutationChina
-
Megan Daly, MDEMD SeronoCompletedMetastatic Non-small Cell Lung Cancer (NSCLC)United States
-
Yonsei UniversityUnknownCompletely Resected NSCLC With Common EGFR MutationsKorea, Republic of
-
University of BaghdadRecruitingTooth Position AnomaliesIraq
-
Suzhou Junjing BioSciences Co., Ltd.Sponsor GmbHRecruitingLocally Advanced or Metastatic NSCLCChina
-
Daiichi SankyoMerck Sharp & Dohme LLC; AstraZenecaActive, not recruitingAdvanced or Metastatic NSCLCUnited States, Spain, Taiwan, Japan, Italy
-
Tianjin Medical University Cancer Institute and...Not yet recruitingNSCLC | EGFR Activating Mutation | Anlotinib | TP53 | Aumolertinib
-
Shandong Provincial HospitalUnknown
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
AkesoNot yet recruitingLocally Advanced or Metastatic NSCLCChina
-
Jiangsu Aosaikang Pharmaceutical Co., Ltd.UnknownLocally Advanced or Metastatic NSCLCChina
-
Genentech, Inc.RecruitingMelanoma | Cervical Cancer | HCC | Gastric Cancer | Esophageal Cancer | NSCLC | Urothelial Carcinoma | HNSCC | Locally Advanced or Metastatic Solid Tumors | TNBC | Clear Cell RCCKorea, Republic of, Netherlands, Spain, United States, Australia, Canada, Belgium
-
Jiangsu Hansoh Pharmaceutical Co., Ltd.RecruitingHase 1/2 Study of HS-10375 in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer(NSCLC)Advanced or Metastatic NSCLCChina